Subject: Clinton Plans To Pick Varmus As Head of NIH Date: Published: 7/8/93 (74 lines) Source: Wall Street Journal. Copyright Dow Jones & Co. Inc. Politics & Policy: Clinton Plans To Pick Varmus As Head of NIH ---- By Marilyn Chase and Hilary Stout Staff Reporters of The Wall Street Journal President Clinton plans to nominate Harold Varmus, a Nobel Prize-winning microbiologist, to be director of the National Institutes of Health, administration officials said. If confirmed by the Senate, Dr. Varmus, 53 years old, would oversee a budget of $10.6 billion and the awarding of grants for research probing virtually all human diseases. A professor of microbiology and biochemistry at the University of California at San Francisco, Dr. Varmus is better known for his bench research than for his experience as an administrator. He has also fought to keep basic research free of political constraints. In April, he helped to circulate a letter with other scientists expressing concern over plans to create an Office of AIDS Research, contending that such an office would wield discretionary power over the funding of AIDS research and could make NIH "a political battleground among disease interest groups." As NIH director he would have to oversee that office, recently created by Congress. UCSF officials said Dr. Varmus is vacationing and doesn't plan to comment until a formal appointment is announced. Dr. Varmus shared the 1989 Nobel Prize for medicine with longtime UCSF colleague J. Michael Bishop. The award acknowledged their work on viral oncogenes, -- the genetic seeds of cancer that are found in viruses and in the genetic code of all animals, from flies to fish to humans. In making its award, the Nobel Committee cited the researchers' "discovery of the cellular origins of retroviral oncogenes." These are special viruses that pass their genetic information in a backward manner. The two scientists observed that the Rous sarcoma virus, a virus that causes cancer in chickens, is also found in normal cells. Their discovery that even sinister oncogenes sometimes play a role in normal cell growth and differentiation helped scientists to understand the interplay between normal growth and malignancy. And the discovery has offered doctors new focal points for cancer research. Since the Nobel Prize-winning work, Drs. Varmus and Bishop have continued to probe the role of oncogenes by creating transgenic mice endowed with extra copies of such genes. Dr. Varmus also has worked on a mouse mammary tumor gene called INT-1. He played a behind-the-scenes role in helping name the AIDS virus -- which had been the subject of a semantic tug-of-war between French researcher Luc Montagnier, who called it LAV, for lymphadenopathy associated virus, and U. S. researcher Robert Gallo, who wanted to name it HTLV-III, for human T-lymphotropic virus. The consensus name he helped choose -- human immunodeficiency virus, or HIV -- has stuck. Meanwhile, conservative groups held a news conference to denounce Joycelyn Elders, Mr. Clinton's choice for surgeon general. Dr. Elders, who was head of the Arkansas Department of Health, has been a supporter of abortion rights. She has set up a program of school health clinics in Arkansas that dispense condoms in districts where the local school board allowed it. Donna Shalala, the secretary of health and human services, issued a statement strongly defending Dr. Elders. "Joycelyn Elders has an outstanding reputation as a forceful and realistic leader for public health ...Those who would portray Dr. Elders as being radical or out of touch with the desires of the American people are distorting her record in an effort to prove their claims," she said. [This article is made available here by Dow Jones Co. for the personal and non-commercial use of callers to this bbs, in the hope that it will be of some help to those who are suffering from the disease and others who are seeking to help them.]